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Birt-Hogg-Dube syndrome (BHD) is a rare disorder caused by mutations in the gene that
encodes folliculin (FLCN) and is inherited in an autosomal dominant manner. BHD is com-
monly accompanied by fibrofolliculomas, renal tumors, multiple pulmonary cysts, and spon-
taneous pneumothorax. The aim of this study was to detect BHD prospectively in patients
undergoing chest computed tomography (CT) scans and to evaluate further the characteris-
tics of BHD in Korea.
Methods
We prospectively checked and reviewed the chest CT scans obtained for 10,883 patients at
Gangnam Severance Hospital, Seoul, Korea, from June 1, 2015 to May 31, 2016. Seven-
teen patients met the study inclusion criteria and underwent screening for FLCN mutation to
confirm BHD. We analyzed the characteristics of the patients confirmed to have BHD and
those for a further 6 patients who had previously been described in Korea.
Results
Six (0.06%) of the 10,883 patients reviewed were diagnosed with BHD. There was no differ-
ence in demographic or clinical features between the patients with BHD (n = 6) and those
without BHD (n = 11). Pneumothorax was present in 50% of the patients with BHD but typi-
cal skin and renal lesions were absent. The maximum size of the cysts in the BHD group
(median 39.4 mm; interquartile range [IQR] 11.4 mm) was significantly larger than that in the
non-BHD group (median 15.8 mm; IQR 7.8 mm; P = 0.001). Variable morphology was seen
in 100.0% of the cysts in the BHD group but in only 18.2% of the cysts in the non-BHD group







Citation: Park HJ, Park CH, Lee SE, Lee GD, Byun
MK, Lee S, et al. (2017) Birt-Hogg-Dube syndrome
prospectively detected by review of chest
computed tomography scans. PLoS ONE 12(2):
e0170713. doi:10.1371/journal.pone.0170713
Editor: Maria Fiammetta Romano, Universita degli
Studi di Napoli Federico II, ITALY
Received: September 28, 2016
Accepted: January 9, 2017
Published: February 2, 2017
Copyright: © 2017 Park et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data are available
within the Dryad repository (doi:10.5061/dryad.
208ht).
Funding: This study was supported by a faculty
research grant of Yonsei University College of
Medicine for 2015 (Grant Number: 6-2015-0032).
The funder had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
(P = 0.002). Nine (95%) of the total of 12 Korean patients with BHD had experienced pneu-
mothorax. Typical skin and renal lesions were present in 20.0% of patients with BHD.
Conclusions
Our findings suggest that BHD can be detected if chest CT scans are read in detail.
Background
Birt–Hogg–Dube syndrome (BHD) is a rare inherited autosomal dominant disease characterized
by multiple pulmonary cysts and by skin and renal lesions. BHD is caused by loss-of-function
mutations in germline folliculin, encoded by FLCN, which has been mapped to chromosome
17p11.2 [1]. Folliculin is thought to function as a tumor suppressor that is associated with the
mammalian target of rapamycin (mTOR) pathway [2]. Defects in folliculin affect the cytoskele-
ton, disrupt the extracellular matrix, and suppress cellular proliferation [3]. FLCN is expressed in
the skin, distal nephron of the kidney, and the pneumocytes of the lung [4]. Therefore, patients
with BHD and FLCNmutations present with multiple lung cysts, cutaneous manifestations
including fibrofolliculoma, trichodiscoma, acrochordon, and perifollicular fibroma, and various
renal tumors.
BHD was first described in the 1970s [2]. In the USA and Europe, typical skin lesions are
found in more than 80% of patients with BHD. Typical renal lesions are noted in about 15–
35% of patients [5,6]. However, recent studies have shown that these typical skin and renal
lesions are less frequently present in Asian patients, including those from China, Japan, and
Taiwan [7–9]. For example, in China, Ding et al. have reported that typical skin and renal
lesions were present in 20% and 0%, respectively, of affected members in 8 families represent-
ing 40 individuals) [7].
Until now, only 430 families with BHD have been reported worldwide, with the largest con-
taining 36 affected members [10,11]. Only 6 cases of BHD have been reported in Korea [12–
15]. Given the rarity of this syndrome, only case reports and case reviews of BHD have been
reported to date. To our knowledge, no prospective study has attempted to diagnose BHD syn-
drome. Further, there are no literature reviews on BHD in Korea.
The purpose of the present study was to detect BHD prospectively in patients undergoing
chest computed tomography (CT) and to analyze the characteristics of BHD in Korea.
Methods
Ethics approval and consent to participate
This study was approved by the institutional review board of the Gangnam Severance Hospital,
Yonsei University Health System (approval number: 3-2015-0122).
Diagnostic criteria
BHD was diagnosed according to the previous literature [1]. Patients were required to fulfill
one major or 2 minor criteria for the diagnosis of BHD. The major inclusion criteria were as
follows: 1) at least 5 fibrofolliculomas or trichodiscomas, of which at least one should be histo-
logically confirmed, with adult onset; and 2) evidence of pathogenic FLCN germline mutation.
The minor inclusion criteria were as follows: 1) bilaterally located multiple basal lung cysts,
with no other apparent cause, with or without spontaneous primary pneumothorax; 2) renal
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cancer with early onset (< 50 years), or with multifocal or bilateral location, or with mixed
chromophobe and oncocytic histology; and 3) a first-degree relative with BHD. In the present
study, typical skin and renal lesions were defined as described above.
Inclusion and exclusion criteria for study enrolment
Inclusion criteria comprised the following: 1) age older than 19 years and 2) chest CT scan
results consistent with BHD [1,16]. We defined pulmonary cysts as air-filled spaces with a
sharply demarcated thin wall less than 3 mm in thickness [17]. The upper and lower zones
were divided at the level of the tracheal carina along the axial direction with a craniocaudal dis-
tribution. Multiple cysts located predominantly in the lower zones were considered to be con-
sistent with BHD. Exclusion criteria were as follows: 1) cysts located predominantly in the
upper zones; 2) cysts located in one lung only; and 3) cysts with characteristics that were more
consistent with other cystic lung diseases, such as lymphangioleiomyomatosis.
Study group
A total of 10,883 patients were identified as having undergone chest CT scans at Gangnam Sev-
erance Hospital, Seoul, Korea, between June 1, 2015 and May 31, 2016. On the basis of a careful
review of the chest CT scans, 18 patients were suspected to have BHD. One patient refused to
participate in the study, leaving 17 patients who were able to be enrolled in this cohort study.
After an FLCN gene study to confirm BHD, we classified these patients into a BHD group (posi-
tive for FLCN mutation) or a non-BHD group (negative for FLCN mutation) as shown in Fig 1.
Fig 1. Study flow chart. CT, computed tomography; BHD, Birt–Hogg–Dube syndrome.
doi:10.1371/journal.pone.0170713.g001
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Chest CT scan protocol
CT scans were performed using one of three scanners: a 16-slice multidetector CT (MDCT)
scanner (Somatom Sensation 16; Siemens Medical Solutions, Erlangen, Germany), a 64-slice
MDCT scanner (Somatom Sensation 64; Siemens Medical Solutions), or a 128-slice MDCT
scanner (Somatom Definition AS+; Siemens Medical Solutions). Scanning was performed in
the supine position from the lung apices to the level of the adrenal glands during inspiration.
After acquiring the scout image to determine the field of view, conventional CT scanning was
performed without contrast enhancement using a helical technique, with a 3 mm or 5 mm
reconstruction interval in the mediastinal window setting. The exposure parameters for the
CT scans were as follows: 80–100 kVp, 50–130 mA, slice thickness, 1 mm or 5 mm, and a
reconstruction increment of 3 mm or 5-mm. Image reconstruction for conventional CT scans
was performed on the scanner’s workstation. All CT images were retrieved on an image
archiving and communication system (Centricity 2.0; GE Medical Systems, Mt Prospect, IL,
USA) and then analyzed using the mediastinal window settings (level, 50 HU; width, 400 HU).
Characteristics of chest CT
Two radiologists (T.H.K and C.H.P, with over 20 and 9 years’ experience in chest radiology
interpretation, respectively) assessed the CT images. The medial and lateral zones divided the
lung field into an inner and outer half; axial distribution (as central, peripheral, or evenly dis-
tributed). Involvement of the costophrenic angle (CPA) was assessed with regard to the rela-
tionship with the visceral pleura (including the interlobular fissure) and were classified into
two groups based on whether the cyst bordered the visceral pleura. A multiseptated cyst was
defined as at least one further cyst with multiseptation. Variable morphology was defined as
being present when patients had all of the following types of cysts: “round-shaped” (a smooth-
surfaced and symmetric cyst with a diameter ratio of long to short axes 1.1); “oval-shaped”
(a smooth-surfaced and symmetric cyst with a diameter ratio of long to short axes > 1.1); and
“irregular-shaped” (a cyst with a shape other than round or oval) [18].
FLCN mutation study
We confirmed the presence of BHD based on the results of FLCN mutation screening as
described elsewhere [12, 15]. Genomic DNA was extracted using an Easy-DNA™ Kit (Invitro-
gen, Carlsbad, CA, USA) from whole blood samples collected in EDTA-containing tubes. The
concentration and quality of genomic DNA were evaluated by Nanodrop (ND-1000, Thermo
Scientific, Wilmington, DE, USA). Primers designed to amplify FLCN exons 4–14 and their
flanking introns were used to perform PCR amplification. The polymerase chain reaction
(PCR) products were then purified using a QIA-quick Gel Extraction Kit (Qiagen, Dusseldorf,
Germany) and directly cycle-sequenced using the relevant PCR primers and a Big Dye Termi-
nator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA).
These sequences were then compared with the reference sequence using Sequencher software
(Gene Codes, Ann Arbor, MI, USA). Pathogenic variants were detected by Sanger sequencing
followed by multiple ligation probe amplification to confirm that there were no large deletions
in FLCN in subjects who were not detected to have pathogenic variants.
Other tests
Abdominal sonography or abdominal CT scans were performed to identify renal lesions. Pul-
monary function tests, including forced volume capacity (FVC), forced expiratory volume in 1
second (FEV1), and FEV1/FVC. were performed to determine whether pulmonary function
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was impaired using commercially available equipment (MS-IOS; Masterlab-IOS, Jaeger,
Wurzburg, Germany). All subjects attended a consultation with a dermatologist (S.E.L) who
carefully performed a full body skin examination to check for skin manifestations. Any lesion
suspected of being associated with BHD was biopsied for pathological analysis. Routine urine
analysis was performed.
Analysis of Korean BHD patients
To analyze the characteristics of BHD in Korea, we combined the findings for the 6 newly
diagnosed patients in the present study with those for the 6 Korean patients with BHD previ-
ously described in the literature [12–15].
Statistical analysis
The continuous patient variables (Table 1) were compared according to BHD status using the
t-test because they were normally distributed throughout the patient cohort, as defined by the
Kolmogorov-Smirnov and Shapiro-Wilk tests. Among the CT characteristics (Table 2), the
minimum and maximum size of cysts were not normally distributed as defined by the same
tests so were assessed using the Mann-Whitney U test. Fisher’s exact test was used to assess the
potential association of clinical and CT characteristics with BHD. All analyses were conducted
using SPSS version 18.0 software (IBM Corp., Armonk, NY, USA). P-values less than 0.05
were considered to be statistically significant.
Results
Demographic and clinical features
Six patients (0.06%) were diagnosed to have BHD in the basis of the FLCN gene study. We
compared the demographic and clinical characteristics between patients in the BHD group
and the non-BHD group. Age, sex, and smoking history were not significantly different
between the two groups. All basic laboratory findings, routine urine analysis, and pulmonary
Table 1. Demographic and clinical features.
BHD (n = 6) Non-BHD (n = 11) P—value
Age (years, mean ± SE) 56.2 ± 6.8 61.4 ± 3.8 0.483
Sex (male:female) 3:3 6:5 > 0.999
Smoking history (never-smoker:smoker) 5:1 4:7 0.600
FVC (%) 94.7 ± 5.7 95.1 ± 7.8 0.967
FEV1 (%) 101.3 ± 7.4 91.3 ± 11.4 0.467
FVE1/FVC (%) 76.1 ± 3.2 72.6 ± 6.9 0.433
Proteinuria 1/5 (20.0%) 1/9 (11.1%) > 0.999
Hematuria 1/5 (20.0%) 3/9 (33.3%) > 0.999
Spontaneous pneumothorax 3/6 (50.0%) 1/11 (9.1%) 0.099
Family history of pneumothorax 2/6 (33.3%) 1/11 (9.1%) 0.515
Typical skin lesions* 0/4 (0.0%) 0/11 (0.0%) N/A
Typical renal lesions† 0/4 (0.0%) 0/9 (0.0%) N/A
*fibrofolliculomas or trichodiscomas
†renal cancer with early onset (< 50 years), or multifocal or bilateral location, or with mixed chromophobe and oncocytic histology.
Abbreviations: WBC, white blood cell; BUN, blood urea nitrogen; AST, aspartate transaminase; ALT, alanine transaminase; FVC, forced vital capacity;
FEV1, forced expiratory volume for 1 second; BHD, Birt-Hogg-Dube syndrome; SE, standard error of mean; NA, not available
doi:10.1371/journal.pone.0170713.t001
BHD prospectively detected by review of chest CT
PLOS ONE | DOI:10.1371/journal.pone.0170713 February 2, 2017 5 / 12
function tests were similar between the two groups. Spontaneous pneumothorax tended to be
more frequent in the BHD group (50.0%) than in the non-BHD group (9.1%), but the differ-
ence was not statistically significant (P = 0.099). The prevalence of family history of pneumo-
thorax was similar between the two groups. Similarly, the prevalence of renal lesions and skin
lesions was not significantly different between the groups. None of the patients in the study
had a family history of typical renal or skin lesions (data not shown).
Characteristics of chest CT scan
Pulmonary cysts observed on chest CT in patients with and without BHD showed markedly
different characteristics (Fig 2). First, the maximum size of the cysts in the BHD group
(median 39.4 mm; interquartile range [IQR] 11.4 mm) was significantly larger than that in the
non-BHD group (median 15.8 mm; IQR 7.8 mm; P = 0.001). Second, all the patients with
BHD had cysts with variable morphology whereas only 18.2% of the patients without BHD
had cysts with variable morphology (P = 0.002). Some patients (33.3%) in the BHD group had
multiseptated cysts but no cysts of this type were found in the non-BHD group (P = 0.110).
However, there was no significant difference in the number of cysts, the dominant location of
these cysts, and CPA involvement between the two groups (Table 2).
Clinical characteristics in BHD group
Typical skin and renal lesions were not observed in our patients. However, some atypical skin
and renal lesions were found as described below. The only skin lesion identified in the 4
Table 2. Characteristics on chest computed tomography scans.
BHD (n = 6) Non-BHD (n = 11) P-value
Number of cysts 0.728
< 20 0 (0.0% 2 (18.2%)
20–40 0 (0.0%) 1 (9.1%)
41–100 4 (66.7%) 7 (63.6%)
> 100 2 (33.3%) 1 (9.1%)
Dominant location 0.549
Central dominant 1 (16.7%) 0 (0.0%)
Evenly distributed 2 (33.3%) 5 (45.5%)
Peripheral dominant 3 (50.0%) 6 (54.5%)
Size of cysts (mm)
Median value of minimum size (IQR) 3.7 (2.1) 4.0 (1.20) 0.537
Median value of maximum size (IQR) 39.4 (11.4) 15.8 (7.8) 0.001*
CPA involvement 0.515
No 4 (66.7%) 10 (90.9%)
Yes 2 (33.3%) 1 (9.1%)
Multiseptated cyst 0.110
No 4 (66.7%) 11 (100.0%)
Yes 2 (33.3%) 0 (0.0%)
Variable morphology 0.002*
No 0 (0.0%) 9 (81.8%)
Yes 6 (100.0%) 2 (18.2%)
*P < 0.05, Mann-Whitney U test and Fisher’s exact test.
Abbreviations: BHD, Birt-Hogg-Dube syndrome; IQR, interquartile range; CPA, costophrenic angle.
doi:10.1371/journal.pone.0170713.t002
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patients who underwent a skin examination by a dermatologist was a white plaque on the nose
in one patient. This lesion was identified on biopsy to be a fibroma. Of the 4 patients with
renal imaging available, 2 had renal lesions, one had multiple renal cysts, and one had clear
cell-type renal cell carcinoma. Only the patient with renal cell carcinoma had proteinuria and
hematuria. Three patients (50.0%) had a history of pneumothorax. All patients had normal
lung function tests (Table 3).
FLCN gene characteristics in BHD group
In the FLCN mutation study, 2 patients were found to harbor c.1285 dupC, while another 2
patients carried c.1557delT; of the remaining 2 patients, one carried c.1215C>G and the other
c.1285delC (Table 3).
Fig 2. Chest CT image findings of pulmonary cysts CT, computed tomography; BHD, Birt–Hogg–Dube syndrome.
doi:10.1371/journal.pone.0170713.g002
Table 3. Clinical and FLCN gene characteristics in BHD group.
No Age Sex Skin lesion Renal lesion Renal function impairment Lung function impairment Pneumothorax
history
FLCN gene mutation
Typical Atypical Typical Atypical Rt Lt
1 43 M None None None None None None 0 1 c.1215C>G
2 57 F None Yes* N/A N/A None None 2 0 c.1285dupC
3 60 M None None None None None None 0 0 c.1285dupC
4 70 F None None None Yes† None None 1 0 c.1557delT
5 31 F N/A N/A N/A N/A None None 0 0 c.1557delT
6 76 M N/A N/A None Yes‡ None§ None 0 0 c.1285delC
*Fibroma on nose
†multiple renal cysts
‡renal cell carcinoma (clear cell type)
§proteinuria and hematuria.
Abbreviations: BHD: Birt-Hogg-Dube syndrome; FLCN, folliculin; N/A, not available.
doi:10.1371/journal.pone.0170713.t003
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Clinical and genetic features of Korean patients with
We analyzed a total of 12 Korean patients with BHD, including subjects detected in the present
study (Patient No. 1–6) and those previously diagnosed with BHD in old literatures (Patient
No. 7–12). The male to female ratio was 5:7, and the mean age was 50.5 ± 15.5 (31–76) years.
Nine patients (75.0%) had a history of pneumothorax. None of the 9 Korean patients with
BHD who underwent renal imaging had typical renal lesions (0.0%), although atypical lesions
(renal cyst or clear cell renal cancer) was present in 3 patients. Two (20.0%) of the 10 patients
who underwent skin examination had typical skin lesions. Atypical lesions (fibromas or pap-
ules with lymphocyte infiltration) were present in 3 patients. Among the total study population
of 12 patients, nine (75.0%) had experienced pneumothorax. Patient 3 had adenocarcinoma of
the lung, and underwent lung biopsy for cancerous lesions and benign cystic lesions. However,
we did not find significant lung pathology related to BHD (Table 3).
The most frequently observed FLCN mutations were c.1285dupC (33.3%). Of the 4 patients
with c.1285dupC, 2 presented typical skin lesions (50.0%). The next most frequently observed
mutation was c.1557delT (25.0%). Patients 11 and 12 were related by blood to patient 10;
hence, they shared the same FLCN mutation, c.882_884delTTC. In addition, c.1215C>G and
c.1285delC were observed in each one patient. There was no significant relationship between
genotype and phenotypic characteristics (Table 4).
Discussion
In this first prospective cohort study, we carefully reviewed the chest CT scans obtained from
10,833 patients over a period of 1 year and diagnosed 6 patients (0.06%) with BHD. Given the
rarity of BHD, no previous study has attempted to detect the syndrome prospectively. Therefore,
Table 4. Clinical and genetic features in Korean patients with BHD.
No Age Sex Typical skin lesion Typical renal
lesion
Lung lesion FLCN gene mutation
Typical Atypical Typical Atypical History of pneumothorax Others
1 43 M None None None None Yes c.1215C>G
2 57 F None Yes† N/A N/A Yes c.1285dupC
3 60 M None None None None None Lung cancer c.1285dupC
4 70 F None None None Yes§ Yes c.1557delT
5 31 F N/A N/A N/A N/A None c.1557delT
6 76 M N/A N/A None Yesk None c.1285delC
7 31 F None Yes‡ None None Yes c.1557delT
8 43 M Fibrofolliculoma, trichodiscoma None N/A N/A Yes c.1285dupC
9 54 M Fibrofolliculoma None None Yes¶ Yes c.1285dupC
10* 40 F None Yes† None None Yes c.882_884delTTC
11* F None None None None Yes c.882_884delTTC
12* F None None None None Yes c.882_884delTTC
*Individuals related to each other by blood
†fibroma
‡papules with lymphocyte infiltration
§multiple renal cysts
krenal cell carcinoma (clear cell type)
¶Single renal cyst.
Abbreviations: BHD, Birt-Hogg-Dube syndrome; FLCN, folliculin; N/A, not available
doi:10.1371/journal.pone.0170713.t004
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the incidence and prevalence of BHD have not yet been reported. We could not determine the
prevalence and incidence of BHD in this study because at least 2 years are needed to define inci-
dence, the research was conducted at a single institution, and the subjects were not representa-
tive of the general population. However, we can assume that many BHD patients have been
underdiagnosed. The present study indicates that BHD can be detected if the cysts are actively
sought during a careful review of chest CT scans.
Pneumothorax is one of main manifestations of BHD. Therefore, many studies have found
BHD in patients previously diagnosed as having spontaneous pneumothorax. BHD is consid-
ered to be the cause in 5–10% of spontaneous pneumothorax cases [16,19]. However, the pres-
ent study included patients with BHD who did not have such a history (50%). Careful review
of the chest CT scans of patients with multiple pulmonary cysts, even those “without a pneu-
mothorax history,” might be helpful in identifying patients with BHD and their family mem-
bers. Therefore, radiologists should carefully review multiple cysts, even in patients without
pneumothorax, to differentiate BHD.
In Korea, the first BHD case was reported in 2008. After the last reported case in 2012,
there have been no reports on BHD since 4 years. Moreover, no Korean reviews of BHD have
been published. This study found typical skin lesions in 20.0% of Korean cases. Typical skin
lesions are present in approximately 90% of patients with BHD in the USA and Europe, but
less frequently in Asia [8,20–23]. For example, in Taiwan, Yang et al reported that no patients
with BHD presented with typical skin lesions [9]. Our study is consistent with this Taiwan
study, showing a low prevalence of skin lesions (20.0%). We did not identify renal lesions in
any of our Korean cases. In the USA and Europe, typical renal lesions are present in 15–35% of
patients with BHD, but are less frequently encountered in Asia. Ding et al. found no renal
lesions, including renal cysts [7]. Our findings are consistent with those of that Asian study.
Thus, we can assume that typical skin and renal lesions are less common in Asian patients
with BHD. In the USA and Europe, spontaneous pneumothorax has been reported to occur in
24–41% of cases [11,24], but has been reported in 68% of cases in China [7]. Our study also
showed high prevalence of spontaneous pneumothorax (75%), consistent with the Asian
study. However, we should consider the critical point that the detection rate of skin and renal
lesions depends on the design of the study. For example, review articles that include many
unrelated subjects detected incidentally may find a high prevalence of skin and renal lesions
[20], whereas family studies including many related subjects detected by family history might
show a relatively low prevalence of these lesions [7]. The prevalence of pneumothorax also
depends on the design of the study. The low prevalence of skin and renal lesions and high
prevalence of pneumothorax in the present study might reflect the fact that we included
patients with pulmonary cysts prospectively. Further, the subjects in our study were relatively
young, whereas many studies have reported that renal lesions typically manifest in older people
[1]. This age-dependent nature of renal lesions may affect the low prevalence of renal lesions
in our study. Importantly, the number of patients with BHD in our study is too small to reach
firm conclusions regarding racial differences. Further studies comparing the prevalence of
skin and renal lesions and pneumothorax according to country are needed.
Our study contained patients with BHD and atypical renal lesions. The presence of multiple
renal cysts (22.2%) in Korean patients with BHD cannot be considered to be a manifestation
of BHD, because the incidence of simple renal cysts in the general population is 20–30% [25].
No typical renal lesions were found in this study, consistent with a previous Chinese study
[11].
Pulmonary function tests were within normal ranges in all our subjects, which is consistent
with previous reports [11,26,27]. Although our patients with BHD had multiple cysts, these
did not affect pulmonary function.
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Our study compared the results of chest CT scans between a BHD group and a non-BHD
group. Large-sized cysts and variable morphology were characteristic CT findings in the
patients with BHD, which again is consistent with previous reports [18,27,28]. CPA involve-
ment was found in 33.3% of our patients with BHD. Tobinoet al. also reported that cysts in
patients with BHD were accompanied by CPA involvement in 40.5% of their patients [18]. In
our study, the cysts were predominantly of the multiseptated type in the BHD group (33.3%)
whereas Agarwal et al. reported that 78% of their patients with BHD had cysts with a multisep-
tal appearance [28]. A larger follow-up study is needed to confirm if these additional character-
istics of cysts in the BHD group are significant when compared with those in the non-BHD
group.
Typical renal cancer was not detected in any of our patients but lung cancer was detected in
one patient (patient 3). We performed biopsy of the lung cysts in patient 3, but could not iden-
tify any pathologic findings suggesting BHD. Moreover, we could not determine if the lung
cancer is associated with BHD. Further genetic analysis of this lung specimen would be useful
to determine whether these lung lesions are associated with BHD. BHD should be detected
early because of its malignancy potential and hereditary nature. Because the principal role of
folliculin is tumor suppression, BHD is associated with cancer, including renal cell cancer and
perhaps even lung cancer [29]. Further, BHD is an inherited autosomal dominant disease, so
patients with BHD have a 50% chance of producing a child with the syndrome. When BHD
is diagnosed, patients and their family members should be followed up regularly with a view
to detecting cancer. Therefore, we recommended that the 6 newly diagnosed BHD patients
should encourage their family members to attend the hospital for check-ups. This prospective
study thus alerted these patients and their families to the need for BHD and cancer screening.
This study has some limitations. First, information on skin and renal lesions was not avail-
able in some patients because of their refusal to undergo further tests. Second, we did not iden-
tify a new diagnostic marker for BHD, so further studies are needed to differentiate BHD from
other cystic lung diseases. Third, we need to perform a follow-up study with detailed genetic
analysis in a non-BHD group to define if other genetic mutations could be related to BHD syn-
drome and if there are other cyst-related genetic diseases. Finally, the extent to which selection
bias may have affected our results is unknown, given that all the patients were from only one
center and most underwent chest CT because they had pulmonary symptoms. Therefore, the
subjects in this study do not represent the general population, and the detection rate of BHD
might have been overestimated.
Conclusions
This prospective cohort study diagnosed 6 patients with BHD in the course of one year at one
institution, indicating that BHD can be detected during careful review of chest CT scans.
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